Everstone invests $270 million in Apothecon Group for a significant stake

Apothecon was founded in 2003 by industry veterans Mahendra Patel, former chief scientific officer of Sandoz and co-founder of Invamed (later acquired by Sandoz), and Joe Renner, former chief operating officer of Sandoz and president of Zydus US. The group has a diversified and expanding portfolio spanning injectable products, oral solids and other dosage forms. It also has in-house capabilities in complex chemistry and a manufacturing and R&D platform that complies with regulated market standards across the US and India.